Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project.
暂无分享,去创建一个
H. Krumholz | J. Curtis | Yongfei Wang | J. Foody | F. Masoudi | E. Havranek | M. Kosiborod | Grace L. Smith
[1] P. Poole‐Wilson,et al. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. , 2004, European heart journal.
[2] J. McMurray,et al. Anemia and Its Relationship to Clinical Outcome in Heart Failure , 2004, Circulation.
[3] Peter C Austin,et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. , 2003, JAMA.
[4] M. Mitka. Researchers probe anemia-heart failure link. , 2003, JAMA.
[5] J. Ryu,et al. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin , 2003 .
[6] Albert W Wu,et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. , 2003, Journal of the American College of Cardiology.
[7] C. O'connor,et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. , 2003, The American journal of cardiology.
[8] P. Poole‐Wilson,et al. Haemoglobin concentration and prognosis in new cases of heart failure , 2003, The Lancet.
[9] D. Mozaffarian,et al. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). , 2003, Journal of the American College of Cardiology.
[10] Harlan M Krumholz,et al. The prognostic importance of anemia in patients with heart failure. , 2003, The American journal of medicine.
[11] C. Lang,et al. Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure , 2003, Circulation.
[12] Paul W Armstrong,et al. Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.
[13] L. Lund,et al. Hemodilution Is Common in Patients With Advanced Heart Failure , 2003, Circulation.
[14] J. Ryu,et al. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin , 2003, Cancer.
[15] D. Silverberg,et al. The importance of anemia and its correction in the management of severe congestive heart failure , 2002, European journal of heart failure.
[16] Harlan M Krumholz,et al. Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.
[17] C. Jurkovitz,et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. , 2002, Journal of the American Society of Nephrology : JASN.
[18] G. Fonarow,et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. , 2002, Journal of the American College of Cardiology.
[19] H. Krumholz,et al. Spectrum of heart failure in older patients: results from the National Heart Failure project. , 2002, American heart journal.
[20] W. Hörl,et al. Effect of erythropoietin on cardiovascular diseases. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] W. Rand,et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.
[22] I. Shapira,et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. , 2001, Journal of the American College of Cardiology.
[23] F. Valderrábano,et al. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. , 2000, Journal of the American Society of Nephrology : JASN.
[24] M. Nichaman,et al. Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project. , 2000, Archives of internal medicine.
[25] Avid,et al. THE EFFECTS OF NORMAL AS COMPARED WITH LOW HEMATOCRIT VALUES IN PATIENTS WITH CARDIAC DISEASE WHO ARE RECEIVING HEMODIALYSIS AND EPOETIN , 2000 .
[26] Y Wang,et al. Predictors of readmission among elderly survivors of admission with heart failure. , 2000, American heart journal.
[27] W. Abraham,et al. Hormones and hemodynamics in heart failure. , 1999, The New England journal of medicine.
[28] J. Zhang,et al. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. , 1998, JAMA.
[29] E. Fisher,et al. Hospital readmission rates for cohorts of Medicare beneficiaries in Boston and New Haven. , 1994, The New England journal of medicine.
[30] P. Poole‐Wilson,et al. Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. , 1993, British heart journal.
[31] J. Concato,et al. Problems of comorbidity in mortality after prostatectomy. , 1992, JAMA.
[32] W. Grove. Statistical Methods for Rates and Proportions, 2nd ed , 1981 .
[33] J. Fleiss,et al. Statistical methods for rates and proportions , 1973 .